Beta Drugs

Beta Drugs Limited is one of India's fastest-growing companies in the branded oncology pharmaceutical market, dedicated to making cancer treatment more accessible and effective. Looking ahead, the company is on a clear path with the ambitious goal of becoming one of the top five players in its field within the next couple of years. A key part of its strategy involves a strong focus on innovation in novel drug delivery systems and formulation development, which helps it stand out from competitors. Its core business involves the manufacturing and trading of a wide range of oncology products, addressing critical needs in cancer care across the country. The company has built strong credibility by supplying high-quality, life-saving oncology medicines and has strategically made them affordable for a broader population. Reflecting its strong performance, the company's consolidated revenues from operations increased by 30.2% in fiscal year 2024, reaching a total of Rs 296 crores.;